These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 752850)

  • 21. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
    Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer.
    Baker LH; Vaughn CB; al-Sarraf M; Reed ML; Vaitkevicius VK
    Cancer; 1974 Feb; 33(2):513-8. PubMed ID: 4812768
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: final report after a 16-year median follow-up duration.
    Misset JL; di Palma M; Delgado M; Plagne R; Chollet P; Fumoleau P; Le Mevel B; Belpomme D; Guerrin J; Fargeot P; Metz R; Ithzaki M; Hill C; Mathé G
    J Clin Oncol; 1996 Apr; 14(4):1136-45. PubMed ID: 8648368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study on adjuvant chemotherapy and hormonal therapy for irradiated inoperable breast cancer.
    Schaake C; Engelsman E; Hamersma E
    Recent Results Cancer Res; 1978; 68():113-7. PubMed ID: 379929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
    Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
    Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast cancer.
    Papaioannou A; Lissaios B; Vasilaros S; Miligos S; Papadimitriou G; Kondilis D; Polychronis A; Kozonis J; Papageorgiou G; Plataniotis G; Razis D; Stathopoulos G; Tsiliakos S; Throuvhlas N; Papavasiliou K; Tsarouhas C; Papaevangelou G
    Cancer; 1983 Apr; 51(7):1284-90. PubMed ID: 6337698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are surgical adjuvant trials altering the course of breast cancer?
    Bonadonna G; Valagussa P; Rossi A; Zucali R; Tancini G; Bajetta E; Brambilla C; De Lena M; Di Fronzo G; Banfi A; Rilke F; Veronesi U
    Semin Oncol; 1978 Dec; 5(4):450-64. PubMed ID: 366757
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R
    Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination chemotherapy for advanced pancreatic carcinoma.
    Costanzi JJ; Panettiere FJ; Wolma FJ
    Tex Med; 1979 Sep; 75(9):50-1. PubMed ID: 494115
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advanced carcinoma of the breast. Results of a polychemotherapeutic protocol].
    Fazio M; Manca A; Rodino A; Cavallero P; Tripodina A
    Minerva Ginecol; 1982 Sep; 34(9):667-70. PubMed ID: 7145204
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of non-resectable (stage III) breast cancer.
    Sponzo RW; Cunningham TJ; Caradonna RR; Antemann R
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1475-8. PubMed ID: 536258
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chemotherapy in curable breast cancer].
    Seradour B; Thomas M
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):175-82. PubMed ID: 353124
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute.
    Buzdar AU; Hortobagyi GN; Marcus CE; Smith TL; Martin R; Gehan EA
    NCI Monogr; 1986; (1):81-5. PubMed ID: 3534594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial chemoimmunotherapy in inflammatory carcinoma of the breast.
    Zylberberg B; Salat-Baroux J; Ravina JH; Dormont D; Amiel JP; Diebold P; Izrael V
    Cancer; 1982 Apr; 49(8):1537-43. PubMed ID: 7066861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
    Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
    Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
    Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
    J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
    Tormey D; Gelman R; Falkson G
    Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
    [No Abstract]   [Full Text] [Related]  

  • 39. [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Vilcoq JR; Bataini JP; Calle R; Fenton J; Mathieu G; Rousseau J; Asselain B
    Bull Cancer; 1981; 68(2):171-86. PubMed ID: 7016224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.
    Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA
    J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.